A comprehensive view of Infections & Infectious Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Pfizer reports positive results in Phase 3 trial of antibiotic combination to treat serious bacterial infections caused by Gram-negative bacteria, including multidrug-resistant pathogens; drug is potential treatment for mutidrug-resistant infections
Published:
June 01, 2023
by Pfizer Inc.
|
Pfizer India and Apollo Hospital launch Center of Excellence for Adult Vaccination to increase the adoption of adult immunizations; center to offer vaccinations for pneumococcal disease, Hepatitis A and B, human papilloma virus, influenza, and others
Published:
May 26, 2023
by United News of India
|
Innoviva's Xacduro gains FDA approval to treat hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex; WHO reports Acinetobacter is the highest-risk bacterial pathogen for human health
Published:
May 25, 2023
by MarketLine
|
PharmaJet providing 5 million needle-free PharmaJet Tropis ID syringes to WHO for polio eradication campaign in Pakistan starting in May; WHO chooses Tropis Precision Delivery System based on cost savings, ease of training, improved immunization coverage
Published:
May 23, 2023
by Business Wire
|
Rutgers University begins late-stage pediatric clinical trials for Pfizer and Valneva's VLA15 Lyme disease vaccine; the vaccine targets the outer surface protein of the bacteria that causes Lyme disease
Published:
May 23, 2023
by Record, The (Bergen County, NJ)
|
Ask us about our Tissue & Hygiene market view
Trending Chart
Interactive chart with headline count